About IPO
IPO is a process by which private companies go public for the first time and their shares are listed (open for buying and selling) in the stock market. IPO helps investors get the first mover advantage and also assists companies to assess their net worth in the primary market.
Benefits of IPO to Investors
-
Opportunity to invest in new companies or startups, otherwise not accessible to general public
-
Allows buying shares at a discount to the market price (post listing)
-
Possibility of significant listing gains, especially in IPOs of high growth companies
-
Absolute transparency with all critical information available in the draft red herring prospectus.
Who can invest in IPO?
While any individual can invest in IPO, there are three distinct categories of IPO investors:
-
Institutional investors or Qualified institutional investors
Commercial banks, mutual fund houses, pension funds, foreign portfolio, trusts, etc. QII allotment is capped at 50% by SEBI.
-
High networth investors
Non-Qualified institutional investors with net worth of more than ₹2 lakhs. Allotment for HNIs is capped at 15% of the overall subscription.
-
Retail investors
Investors with net worth of less than ₹2 lakhs. Minimum allotment capped at 35%.
How to apply for IPO @
How to enhance chances of IPO allotment?
News
-
Indegene IPO subscribed 7.34 times
The initial public offer (IPO) of Indegene received 21,20,23,944 bids for shares as against 2,88,66,677 shares on offer, according to stock exchange data at 17:00 IST on Tuesday (7 May 2024). The issue was subscribed 7.34 times.
The issue opened for bidding on Monday (6 May 2024) and it will close on Wednesday (8 May 2024). The price band of the IPO is fixed at Rs 430 to 452 per share. An investor can bid for a minimum of 33 equity shares and in multiples thereof.
The offer comprises fresh issue of equity shares worth up to Rs 760 crore and an offer for sale of 2,39,32,732 equity shares aggregating up to Rs 1,081.76 crore.
The objectives of the fresh issue include Rs 391 crore for repayment/prepayment of debt; Rs 103 crore to fund working capital requirement and the remaining amount to be used for general corporate purposes and inorganic growth.
Ahead of the IPO, Indegene on Friday, 3 May 2024, raised Rs 548.77 crore from anchor investors. The board allotted 1.21 crore shares at Rs 452 each to 36 anchor investors.
Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. The company assists in drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales and marketing.
The company provides services such as enterprise commercial solutions, omnichannel activation, enterprise medical solutions and enterprise clinical solutions and consultancy services.
The firm reported a net profit of Rs 241.90 crore and sales of Rs 1,916.61 crore for the nine months ended on 31 December 2023.
Powered by Capital Market - Live News
-
Indegene IPO subscribed 1.67 times
The initial public offer (IPO) of Indegene received 4,80,93,837 bids for shares as against 2,88,66,677 shares on offer, according to stock exchange data at 17:00 IST on Monday (6 May 2024). The issue was subscribed 1.67 times.
The issue opened for bidding on Monday (6 May 2024) and it will close on Wednesday (8 May 2024). The price band of the IPO is fixed at Rs 430 to 452 per share. An investor can bid for a minimum of 33 equity shares and in multiples thereof.
The offer comprises fresh issue of equity shares worth up to Rs 760 crore and an offer for sale of 2,39,32,732 equity shares aggregating up to Rs 1,081.76 crore.
The objectives of the fresh issue include Rs 391 crore for repayment/prepayment of debt; Rs 103 crore to fund working capital requirement and the remaining amount to be used for general corporate purposes and inorganic growth.
Ahead of the IPO, Indegene on Friday, 3 May 2024, raised Rs 548.77 crore from anchor investors. The board allotted 1.21 crore shares at Rs 452 each to 36 anchor investors.
Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. The company assists in drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales and marketing.
The company provides services such as enterprise commercial solutions, omnichannel activation, enterprise medical solutions and enterprise clinical solutions and consultancy services.
The firm reported a net profit of Rs 241.90 crore and sales of Rs 1,916.61 crore for the nine months ended on 31 December 2023.
Powered by Capital Market - Live News
-
JNK India IPO ends with decent subscription
The initial public offer (IPO) of JNK India received 31,17,66,156 bids for shares as against 1,10,83,278 shares on offer. The issue was subscribed 28.13 times.
The Qualified Institutional Buyers (QIBs) category was subscribed 75.72 times. The Non Institutional Investors (NIIs) category was subscribed 23.26 times. The Retail Individual Investors (RIIs) category was subscribed 4.11 times.
The issue opened for bidding on 23 April 2024 and closed on 25 April 2024. The price band of the IPO was fixed at Rs 395 to Rs 415 per share.
The offer comprised of a fresh issue of equity shares of Rs 300 crore and an offer for sale (OFS) of up to 84,21,052 equity shares from the promoter selling shareholders and individual selling shareholders.
Of the net proceeds from the fresh issue, about Rs 262.69 crore will be utilized for funding working capital requirement and balance towards general corporate purposes. The selling shareholders will be entitled to the proceeds from the OFS (net of its portion of the offer-related expenses). The company will not receive any proceeds from the OFS.
As on 31 January 2024, its borrowings were Rs 157.06 crore on a consolidated basis.
Ahead of the IPO, JNK India on 22 April 2024 raised Rs 194.84 crore from anchor investors. The board allotted 46.94 lakh shares at Rs 415 each to 19 anchor investors.
JNK India manufactures heating equipment such as process-fired heaters, reformers, and cracking furnaces required in process industries such as for oil and gas refineries, petrochemical and fertilizer industries. Over the years, the company diversified into flares and incinerator systems and has been developing capabilities in the renewable sector with green hydrogen.
The firm reported a net profit of Rs 46.21 crore and sales of Rs 253.39 crore for the nine months ended on 31 December 2023.
Powered by Capital Market - Live News
-
JNK India IPO subscribed 28.07 times
The initial public offer (IPO) of JNK India received 31,10,55,912 bids for shares as against 1,10,83,278 shares on offer, according to stock exchange data at 17:30 IST on Thursday (25 April 2024). The issue was subscribed 28.07 times.
The issue opened for bidding on Tuesday (23 April 2024) and it will close on Thursday (25 April 2024). The price band of the IPO is fixed at Rs 395 to Rs 415 per share. An investor can bid for a minimum of 36 equity shares and in multiples thereof.
The offer comprises of a fresh issue of equity shares of Rs 300 crore and an offer for sale (OFS) of up to 84,21,052 equity shares from the promoter selling shareholders and individual selling shareholders.
Of the net proceeds from the fresh issue, about Rs 262.69 crore will be utilized for funding working capital requirement and balance towards general corporate purposes. The selling shareholders will be entitled to the proceeds from the OFS (net of its portion of the offer-related expenses). The company will not receive any proceeds from the OFS.
As on 31 January 2024, its borrowings were Rs 157.06 crore on a consolidated basis.
Ahead of the IPO, JNK India on Monday, 22 April 2024 raised Rs 194.84 crore from anchor investors. The board allotted 46.94 lakh shares at Rs 415 each to 19 anchor investors.
JNK India manufactures heating equipment such as process-fired heaters, reformers, and cracking furnaces required in process industries such as for oil and gas refineries, petrochemical and fertilizer industries. Over the years, the company diversified into flares and incinerator systems and has been developing capabilities in the renewable sector with green hydrogen.
The firm reported a net profit of Rs 46.21 crore and sales of Rs 253.39 crore for the nine months ended on 31 December 2023.
Powered by Capital Market - Live News
-
JNK India IPO subscribed 1.03 times
The initial public offer (IPO) of JNK India received 1,14,14,556 bids for shares as against 1,10,83,278 shares on offer, according to stock exchange data at 17:00 IST on Wednesday (24 April 2024). The issue was subscribed 1.03 times.
The issue opened for bidding on Tuesday (23 April 2024) and it will close on Thursday (25 April 2024). The price band of the IPO is fixed at Rs 395 to Rs 415 per share. An investor can bid for a minimum of 36 equity shares and in multiples thereof.
The offer comprises of a fresh issue of equity shares of Rs 300 crore and an offer for sale (OFS) of up to 84,21,052 equity shares from the promoter selling shareholders and individual selling shareholders.
Of the net proceeds from the fresh issue, about Rs 262.69 crore will be utilized for funding working capital requirement and balance towards general corporate purposes. The selling shareholders will be entitled to the proceeds from the OFS (net of its portion of the offer-related expenses). The company will not receive any proceeds from the OFS.
As on 31 January 2024, its borrowings were Rs 157.06 crore on a consolidated basis.
Ahead of the IPO, JNK India on Monday, 22 April 2024 raised Rs 194.84 crore from anchor investors. The board allotted 46.94 lakh shares at Rs 415 each to 19 anchor investors.
JNK India manufactures heating equipment such as process-fired heaters, reformers, and cracking furnaces required in process industries such as for oil and gas refineries, petrochemical and fertilizer industries. Over the years, the company diversified into flares and incinerator systems and has been developing capabilities in the renewable sector with green hydrogen.
The firm reported a net profit of Rs 46.21 crore and sales of Rs 253.39 crore for the nine months ended on 31 December 2023.
Powered by Capital Market - Live News